Cutaneous Involvement of Waldenström Macroglobulinemia With MYD88 L265P Mutation Identified in Lesional Skin

Key Result

The MYD88 L265P mutation was identified in the lesional skin of cutaneous Waldenström macroglobulinemia.

Key Points

• The aim is to explore the cutaneous manifestations of Waldenström Macroglobulinemia and the role of the MYD88 L265P mutation.
• Examine skin lesions for evidence of Waldenström Macroglobulinemia.
• Identify MYD88 L265P mutation in affected tissues.
• Cutaneous lesions were observed in the patient diagnosed with Waldenström Macroglobulinemia.
• MYD88 L265P mutation was detected in the lesional skin.